Total Debt
$36.3M
Net Debt
-$225.9M
Cytek Biosciences, Inc. currently has $36.3M in total debt. Net debt is -$225.9M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
CTKB • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.04 | 0.26 | -0.23Net Cash | 0.45 | 8.1% |
| 2025-12-31 | 0.02 | 0.26 | -0.24Net Cash | 0.46 | 5.1% |
| 2025-09-30 | 0.04 | 0.26 | -0.23Net Cash | 0.49 | 7.1% |
| 2025-06-30 | 0.02 | 0.26 | -0.24Net Cash | 0.49 | 4.8% |
| 2025-03-31 | 0.02 | 0.27 | -0.25Net Cash | 0.48 | 3.3% |
| 2024-12-31 | 0.02 | 0.28 | -0.26Net Cash | 0.50 | 3.4% |
| 2024-09-30 | 0.01 | 0.28 | -0.26Net Cash | 0.49 | 3.0% |
| 2024-06-30 | 0.01 | 0.28 | -0.26Net Cash | 0.48 | 2.8% |
| 2024-03-31 | 0.01 | 0.27 | -0.26Net Cash | 0.49 | 2.9% |
| 2023-12-31 | 0.01 | 0.26 | -0.25Net Cash | 0.49 | 2.9% |
| 2023-09-30 | 0.02 | 0.29 | -0.27Net Cash | 0.52 | 2.9% |
| 2023-06-30 | 0.02 | 0.30 | -0.28Net Cash | 0.53 | 3.1% |
| 2023-03-31 | 0.02 | 0.30 | -0.28Net Cash | 0.52 | 3.3% |
| 2022-12-31 | 0.02 | 0.34 | -0.32Net Cash | 0.52 | 3.5% |
| 2022-09-30 | 0.02 | 0.34 | -0.33Net Cash | 0.50 | 3.2% |
| 2022-06-30 | 0.01 | 0.35 | -0.34Net Cash | 0.49 | 3.0% |
| 2022-03-31 | 0.01 | 0.36 | -0.35Net Cash | 0.49 | 3.1% |
| 2021-12-31 | 0.00 | 0.36 | -0.36Net Cash | 0.46 | 0.0% |
| 2021-09-30 | 0.00 | 0.38 | -0.38Net Cash | 0.45 | 0.0% |
| 2021-06-30 | 0.00 | 0.16 | -0.16Net Cash | 0.23 | 0.0% |
| 2021-03-31 | 0.00 | 0.17 | -0.17Net Cash | 0.22 | 1.2% |
| 2020-12-31 | 0.00 | 0.17 | -0.16Net Cash | 0.22 | 1.3% |
| 2020-03-31 | 0.00 | 0.03 | -0.03Net Cash | 0.00 | — |